Armata Pharma - רווח נקי למניה ב-12 החודשים האחרונים ARMP

לוגו של חברה ציבורית Armata Pharmaceuticals Inc (ARMP)

Armata Pharmaceuticals (ARMP) is developing advanced methods to combat resistant bacteria using bacteriophages, addressing the inefficiency of antibiotics. The company's operations are independent of GDP phases or seasonality, relying instead on venture capital. The market trend for EPS (TTM) is currently fixed at -163.20. However, the business faces significant risks due to pre-commercial stage losses and the likelihood of secondary offerings before the completion of drug trials.

Armata Pharma - רווח למניה בשנים עשר החודשים האחרונים ARMP (תקופה 11.02.2024 - 16.11.2026)

Armata Pharmaceuticals Inc - פילוחים אנליטיים ומדדי מפתח (ARMP)

- פרטי שווי השוק של המנפיק:
ניתוח ראשוני של החברה:ARMP (Armata Pharmaceuticals, Inc.)
סחורת הדגל של Armata Pharmaceuticals, Inc.

This metric is calculated as the percentage change in net income per share over the last 12 months relative to the same period last year. The metric demonstrates the actual return on equity, stripped of one-time accounting adjustments and tax distortions. For Armata Pharmaceuticals (ARMP), such dynamics reflect the efficiency of commercializing patented bacteriophages under strict regulatory oversight. By analyzing the EPS YoY TTM percentage change trend, an investor assesses the financial stability of the company's scientific foundation.